Pharmafile Logo
Pharmafocus logo
Advanced Search

Cautious welcome for government crackdown on extremists

August 5, 2004

News

FDA approves Lipitor for reducing heart attack risk

August 5, 2004

The FDA has approved Pfizer's cholesterol-lowering statin Lipitor for a new indication – the prevention of cardiovascular disease by reducing …

News

Pharma to work with NPC on pre-launch updates

August 4, 2004

News of new medicines on the horizon should be communicated better and earlier to NHS clinicians and managers following a …

News

‘Double boost’ for Seoquel in bipolar disorder and dementia

August 4, 2004

AstraZeneca announced a 'double boost' for its atypical antipsychotic Seroquel as it gained FDA approval for the long-term treatment of …

News

Lilly to disclose clinical trial results

August 4, 2004

Lilly has responded to calls for greater disclosure of clinical trial results by pledging to publish more data through its …

News

NHS researchers to test cancer gene therapy

August 4, 2004

News

Turning clinical trials on their head

August 4, 2004

Increased pressure to get more products to market faster, with a close eye on the total cost of development and …

Feature

Trading places and switching sides

July 29, 2004

Power, intrigue, corruption and more than a dash of Hollywood: yes, the Mafia has it all. And just like La …

Feature

New diabetes drug superior to Lantus, says Lilly

July 29, 2004

Amylin Pharmaceuticals and partners Lilly say patients taking their new diabetes drug exenatide achieved similar glycaemic control to those on …

News

4.2 billion PFI hospital investments given go-ahead

July 29, 2004

News

Pharma defies extremists with

July 29, 2004

News

Generics continue to harass GSK

July 29, 2004

News

‘Patents versus patients’ still part of the problem

July 26, 2004

The head of the UN AIDS programme has said there must be an end to divisive "institutional agendas" and greater …

News

Vytorin poised to benefit from controversial US guidelines

July 26, 2004

New US guidelines for lowering cholesterol targets in at-risk patients have stirred controversy after experts were accused of not declaring …

News

Asthma and hypertension next in POM to P revolution

July 26, 2004

News

R&D chief loses his cool over Swedish attitude

July 26, 2004

AstraZeneca says it remains committed to its research operations in Sweden – with its headquarters south-west of Stockholm – after …

News

Merck enlist Avenue for Erbitux launch

July 22, 2004

Merck UK has launched its first cancer treatment, Erbitux, with a communications programme led by Avenue HKM.Avenue was selected after …

News

Targets out and standards in for next NHS three-year plan

July 22, 2004

The government has unveiled its masterplan for the NHS in the three years from 2005/6, slashing the number of national …

News

Falling stars blight NHS performance ratings

July 21, 2004

Four of the government's flagship foundation trusts have lost their three star ratings in the latest review, prompting further criticism …

News

New Europe: always read the label

July 21, 2004

In May 2004, ten emerging economies across the east of Europe became members of the European Union. This might seem …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026